

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 6.23300817 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.59265209 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.58994771 |
| 4 | glutamate secretion (GO:0014047) | 5.51921219 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.35901502 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.34023967 |
| 7 | vocalization behavior (GO:0071625) | 5.24593378 |
| 8 | cerebellar Purkinje cell differentiation (GO:0021702) | 5.05037250 |
| 9 | L-amino acid import (GO:0043092) | 5.02119563 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.98809698 |
| 11 | protein localization to synapse (GO:0035418) | 4.88979154 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.84886795 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.63861223 |
| 14 | neurofilament cytoskeleton organization (GO:0060052) | 4.58511665 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.58230057 |
| 16 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.52058119 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.43020471 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.32441398 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.31661701 |
| 20 | amino acid import (GO:0043090) | 4.31535242 |
| 21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.29831728 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.26123369 |
| 23 | glutamate receptor signaling pathway (GO:0007215) | 4.21711871 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.20985652 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.14947524 |
| 26 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.10855108 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.08286771 |
| 28 | neuromuscular process controlling posture (GO:0050884) | 4.07739506 |
| 29 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.02044047 |
| 30 | potassium ion homeostasis (GO:0055075) | 4.01937083 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 4.01525232 |
| 32 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.98608313 |
| 33 | membrane depolarization during action potential (GO:0086010) | 3.93549057 |
| 34 | exploration behavior (GO:0035640) | 3.91571616 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.87732189 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 3.85930278 |
| 37 | axon ensheathment in central nervous system (GO:0032291) | 3.82634280 |
| 38 | central nervous system myelination (GO:0022010) | 3.82634280 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79843121 |
| 40 | innervation (GO:0060384) | 3.78931329 |
| 41 | cell migration in hindbrain (GO:0021535) | 3.76832229 |
| 42 | negative regulation of dendrite development (GO:2000171) | 3.76335868 |
| 43 | regulation of synapse structural plasticity (GO:0051823) | 3.75728723 |
| 44 | C4-dicarboxylate transport (GO:0015740) | 3.74641749 |
| 45 | potassium ion import (GO:0010107) | 3.73027371 |
| 46 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.69464383 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.67379022 |
| 48 | positive regulation of membrane potential (GO:0045838) | 3.67226711 |
| 49 | cellular sodium ion homeostasis (GO:0006883) | 3.67142740 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.63976983 |
| 51 | neuronal ion channel clustering (GO:0045161) | 3.63539420 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.57535968 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.55579804 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.55317923 |
| 55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.53559754 |
| 56 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.50967173 |
| 57 | serotonin metabolic process (GO:0042428) | 3.45882912 |
| 58 | neurotransmitter transport (GO:0006836) | 3.41800901 |
| 59 | membrane depolarization (GO:0051899) | 3.40423844 |
| 60 | cerebellar granule cell differentiation (GO:0021707) | 3.36867086 |
| 61 | long-term memory (GO:0007616) | 3.36463837 |
| 62 | regulation of synaptic plasticity (GO:0048167) | 3.35588441 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 3.34156338 |
| 64 | regulation of neurotransmitter secretion (GO:0046928) | 3.33275604 |
| 65 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.31088868 |
| 66 | cell communication by electrical coupling (GO:0010644) | 3.29271240 |
| 67 | membrane hyperpolarization (GO:0060081) | 3.28246367 |
| 68 | neuromuscular process controlling balance (GO:0050885) | 3.27835209 |
| 69 | cell differentiation in hindbrain (GO:0021533) | 3.27571173 |
| 70 | presynaptic membrane assembly (GO:0097105) | 3.26413442 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26287180 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.25927631 |
| 73 | neuromuscular process (GO:0050905) | 3.23526095 |
| 74 | cAMP-mediated signaling (GO:0019933) | 3.23114776 |
| 75 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21252878 |
| 76 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.20924805 |
| 77 | transmission of nerve impulse (GO:0019226) | 3.20490864 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.19821051 |
| 79 | detection of calcium ion (GO:0005513) | 3.19445102 |
| 80 | auditory behavior (GO:0031223) | 3.19232001 |
| 81 | neurotransmitter uptake (GO:0001504) | 3.19064625 |
| 82 | regulation of vesicle fusion (GO:0031338) | 3.18410283 |
| 83 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.16413640 |
| 84 | striatum development (GO:0021756) | 3.15988901 |
| 85 | response to histamine (GO:0034776) | 3.13075108 |
| 86 | positive regulation of synapse maturation (GO:0090129) | 3.10716237 |
| 87 | urinary tract smooth muscle contraction (GO:0014848) | 3.10639134 |
| 88 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.10355529 |
| 89 | adult walking behavior (GO:0007628) | 3.08917415 |
| 90 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.08740234 |
| 91 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.08513652 |
| 92 | proline transport (GO:0015824) | 3.08493109 |
| 93 | mechanosensory behavior (GO:0007638) | 3.08448163 |
| 94 | regulation of synapse maturation (GO:0090128) | 3.07739479 |
| 95 | cell communication involved in cardiac conduction (GO:0086065) | 3.07011486 |
| 96 | neuron recognition (GO:0008038) | 3.06279780 |
| 97 | response to auditory stimulus (GO:0010996) | 3.06050685 |
| 98 | sodium ion export (GO:0071436) | 3.05932380 |
| 99 | establishment of synaptic vesicle localization (GO:0097480) | 3.05442733 |
| 100 | synaptic vesicle transport (GO:0048489) | 3.05442733 |
| 101 | synaptic transmission (GO:0007268) | 3.05147519 |
| 102 | layer formation in cerebral cortex (GO:0021819) | 3.02938782 |
| 103 | dendritic spine morphogenesis (GO:0060997) | 3.02582886 |
| 104 | regulation of neurotransmitter transport (GO:0051588) | 3.02541988 |
| 105 | presynaptic membrane organization (GO:0097090) | 3.02339470 |
| 106 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.02065969 |
| 107 | organelle transport along microtubule (GO:0072384) | 2.99905030 |
| 108 | synapse assembly (GO:0007416) | 2.99330526 |
| 109 | negative regulation of neurotransmitter transport (GO:0051589) | 2.98185889 |
| 110 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.97777922 |
| 111 | primary amino compound metabolic process (GO:1901160) | 2.96848045 |
| 112 | vesicle transport along microtubule (GO:0047496) | 2.96162676 |
| 113 | membrane assembly (GO:0071709) | 2.95823118 |
| 114 | activation of protein kinase A activity (GO:0034199) | 2.95496783 |
| 115 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.94179795 |
| 116 | axonal fasciculation (GO:0007413) | 2.93800715 |
| 117 | postsynaptic membrane organization (GO:0001941) | 2.93265545 |
| 118 | regulation of membrane repolarization (GO:0060306) | 2.92588656 |
| 119 | dendrite morphogenesis (GO:0048813) | 2.92343881 |
| 120 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.92294206 |
| 121 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.89765391 |
| 122 | startle response (GO:0001964) | 2.89601201 |
| 123 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.88585493 |
| 124 | axon cargo transport (GO:0008088) | 2.87620718 |
| 125 | cochlea development (GO:0090102) | 2.87273293 |
| 126 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85968261 |
| 127 | chemosensory behavior (GO:0007635) | 2.84849766 |
| 128 | behavioral defense response (GO:0002209) | 2.84640036 |
| 129 | behavioral fear response (GO:0001662) | 2.84640036 |
| 130 | establishment of nucleus localization (GO:0040023) | 2.82167296 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.95448450 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.35929004 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.04620988 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.98650195 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.97418160 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54567477 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54567477 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.49008256 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.47463022 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44615840 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.40192996 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.39321246 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35936479 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31380711 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.29667073 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28985071 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21691805 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.20890801 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16792515 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.16451718 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.04025449 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03749374 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01006891 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97435858 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.97244141 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.96490068 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.96454717 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96304712 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.95272765 |
| 30 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91239910 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91230627 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.87199226 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.78974899 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72541298 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69512234 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66648365 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.63995967 |
| 38 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.53154959 |
| 39 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50755921 |
| 40 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50619053 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50164308 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47840850 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45649257 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45110469 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45060745 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44258150 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43580990 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42527090 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.40740968 |
| 50 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.39701308 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39605608 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37799405 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.36164283 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35695970 |
| 55 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34425648 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30366061 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30248384 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29761686 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.29484825 |
| 60 | AR_19668381_ChIP-Seq_PC3_Human | 1.27850647 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.27675300 |
| 62 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27256749 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26988746 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26151200 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25224365 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24846788 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24697360 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23167882 |
| 69 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22806971 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22167954 |
| 71 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18788740 |
| 72 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16359192 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16045444 |
| 74 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15864651 |
| 75 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15739494 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15071595 |
| 77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12882278 |
| 78 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.12591592 |
| 79 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11974571 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11736563 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11352478 |
| 82 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08393517 |
| 83 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08301670 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08298202 |
| 85 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.07921850 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07744182 |
| 87 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07032756 |
| 88 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06803781 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06753829 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05417082 |
| 91 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05219461 |
| 92 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04982352 |
| 93 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04805153 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03635180 |
| 95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03238932 |
| 96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03067020 |
| 97 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02643611 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.02446612 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02376487 |
| 100 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01490767 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00538944 |
| 102 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00140087 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00140087 |
| 104 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99671206 |
| 105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98871547 |
| 106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98251494 |
| 107 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98069565 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97078635 |
| 109 | JUN_21703547_ChIP-Seq_K562_Human | 0.96518121 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96463667 |
| 111 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95098194 |
| 112 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93024106 |
| 113 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91138061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.14839034 |
| 2 | MP0003880_abnormal_central_pattern | 4.93903849 |
| 3 | MP0004270_analgesia | 4.10194411 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.98954657 |
| 5 | MP0009046_muscle_twitch | 3.76361472 |
| 6 | MP0009745_abnormal_behavioral_response | 3.17783859 |
| 7 | MP0002064_seizures | 3.16504760 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.08817145 |
| 9 | MP0002735_abnormal_chemical_nociception | 3.08753017 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.06522257 |
| 11 | MP0002272_abnormal_nervous_system | 2.81733326 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.72433492 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.69325202 |
| 14 | MP0001486_abnormal_startle_reflex | 2.61794369 |
| 15 | MP0002736_abnormal_nociception_after | 2.45694565 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.38763809 |
| 17 | MP0002067_abnormal_sensory_capabilities | 2.33436084 |
| 18 | MP0004858_abnormal_nervous_system | 2.31741619 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.27905605 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.20221006 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.15211668 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.09252774 |
| 23 | MP0008569_lethality_at_weaning | 2.05308269 |
| 24 | MP0002184_abnormal_innervation | 2.03056773 |
| 25 | MP0001970_abnormal_pain_threshold | 1.99059904 |
| 26 | MP0003879_abnormal_hair_cell | 1.92893786 |
| 27 | MP0001984_abnormal_olfaction | 1.84206501 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.78791478 |
| 29 | MP0002822_catalepsy | 1.78041517 |
| 30 | MP0004924_abnormal_behavior | 1.76875941 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.76875941 |
| 32 | MP0002557_abnormal_social/conspecific_i | 1.74528905 |
| 33 | MP0000778_abnormal_nervous_system | 1.67657398 |
| 34 | MP0002909_abnormal_adrenal_gland | 1.63256033 |
| 35 | MP0000955_abnormal_spinal_cord | 1.60523380 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.59462562 |
| 37 | MP0003329_amyloid_beta_deposits | 1.57601837 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.51666852 |
| 39 | MP0004142_abnormal_muscle_tone | 1.50283436 |
| 40 | MP0002882_abnormal_neuron_morphology | 1.47814094 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.43699244 |
| 42 | MP0003633_abnormal_nervous_system | 1.43338014 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.40961516 |
| 44 | MP0001188_hyperpigmentation | 1.40575386 |
| 45 | MP0001502_abnormal_circadian_rhythm | 1.40462990 |
| 46 | MP0003787_abnormal_imprinting | 1.37557251 |
| 47 | MP0000751_myopathy | 1.25471401 |
| 48 | MP0002229_neurodegeneration | 1.25378334 |
| 49 | MP0003631_nervous_system_phenotype | 1.19460912 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.15829864 |
| 51 | MP0003122_maternal_imprinting | 1.13049123 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.11317739 |
| 53 | MP0008057_abnormal_DNA_replication | 1.10723617 |
| 54 | MP0008872_abnormal_physiological_respon | 1.09408255 |
| 55 | MP0000566_synostosis | 1.08449353 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.07325418 |
| 57 | MP0001529_abnormal_vocalization | 1.06341832 |
| 58 | MP0004742_abnormal_vestibular_system | 1.04654103 |
| 59 | MP0004130_abnormal_muscle_cell | 1.03167690 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.00811115 |
| 61 | MP0002152_abnormal_brain_morphology | 1.00610035 |
| 62 | MP0001905_abnormal_dopamine_level | 0.99342772 |
| 63 | MP0008874_decreased_physiological_sensi | 0.98054054 |
| 64 | MP0001963_abnormal_hearing_physiology | 0.97486955 |
| 65 | MP0005187_abnormal_penis_morphology | 0.94970949 |
| 66 | MP0001485_abnormal_pinna_reflex | 0.94510951 |
| 67 | MP0004085_abnormal_heartbeat | 0.92816505 |
| 68 | MP0001986_abnormal_taste_sensitivity | 0.91197207 |
| 69 | MP0004147_increased_porphyrin_level | 0.90679834 |
| 70 | MP0002752_abnormal_somatic_nervous | 0.90253112 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.84333733 |
| 72 | MP0003646_muscle_fatigue | 0.83153474 |
| 73 | MP0003868_abnormal_feces_composition | 0.80627452 |
| 74 | MP0004885_abnormal_endolymph | 0.80277586 |
| 75 | MP0004233_abnormal_muscle_weight | 0.80116997 |
| 76 | MP0003045_fibrosis | 0.79456444 |
| 77 | MP0002069_abnormal_eating/drinking_beha | 0.79318854 |
| 78 | MP0003634_abnormal_glial_cell | 0.78688545 |
| 79 | MP0003632_abnormal_nervous_system | 0.78399050 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.76961371 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.76584457 |
| 82 | MP0000026_abnormal_inner_ear | 0.74557329 |
| 83 | MP0004043_abnormal_pH_regulation | 0.73834033 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.72371787 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.72207920 |
| 86 | MP0005535_abnormal_body_temperature | 0.71418999 |
| 87 | MP0005623_abnormal_meninges_morphology | 0.70317389 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.67978299 |
| 89 | MP0003121_genomic_imprinting | 0.67466214 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.67080772 |
| 91 | MP0004484_altered_response_of | 0.66431124 |
| 92 | MP0005499_abnormal_olfactory_system | 0.66296526 |
| 93 | MP0005394_taste/olfaction_phenotype | 0.66296526 |
| 94 | MP0003861_abnormal_nervous_system | 0.65938697 |
| 95 | MP0005409_darkened_coat_color | 0.65576644 |
| 96 | MP0004036_abnormal_muscle_relaxation | 0.65362230 |
| 97 | MP0000604_amyloidosis | 0.65309425 |
| 98 | MP0008004_abnormal_stomach_pH | 0.63606081 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.62598586 |
| 100 | MP0000920_abnormal_myelination | 0.61903955 |
| 101 | MP0000749_muscle_degeneration | 0.60949003 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.59950631 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.57339454 |
| 104 | MP0003690_abnormal_glial_cell | 0.57304577 |
| 105 | MP0001177_atelectasis | 0.57264604 |
| 106 | MP0001943_abnormal_respiration | 0.56970162 |
| 107 | MP0010769_abnormal_survival | 0.56243699 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.55446704 |
| 109 | MP0002082_postnatal_lethality | 0.55039220 |
| 110 | MP0010770_preweaning_lethality | 0.55039220 |
| 111 | MP0005670_abnormal_white_adipose | 0.54275115 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.53893586 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.53215180 |
| 114 | MP0010768_mortality/aging | 0.52650112 |
| 115 | MP0005253_abnormal_eye_physiology | 0.51005951 |
| 116 | MP0003938_abnormal_ear_development | 0.49925210 |
| 117 | MP0005174_abnormal_tail_pigmentation | 0.48599039 |
| 118 | MP0003123_paternal_imprinting | 0.48058051 |
| 119 | MP0003956_abnormal_body_size | 0.46917937 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.45216720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.26600115 |
| 2 | Myokymia (HP:0002411) | 7.33690358 |
| 3 | Focal seizures (HP:0007359) | 6.08581199 |
| 4 | Febrile seizures (HP:0002373) | 5.82265283 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 5.55940616 |
| 6 | Atonic seizures (HP:0010819) | 5.35250017 |
| 7 | Epileptic encephalopathy (HP:0200134) | 5.34715958 |
| 8 | Absence seizures (HP:0002121) | 4.66514955 |
| 9 | Action tremor (HP:0002345) | 4.56251742 |
| 10 | Gaze-evoked nystagmus (HP:0000640) | 4.25901259 |
| 11 | Dialeptic seizures (HP:0011146) | 4.15098213 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 4.11639337 |
| 13 | Genetic anticipation (HP:0003743) | 4.10006835 |
| 14 | Visual hallucinations (HP:0002367) | 3.84786016 |
| 15 | Scanning speech (HP:0002168) | 3.83794566 |
| 16 | Truncal ataxia (HP:0002078) | 3.76559627 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.59868586 |
| 18 | Hyperventilation (HP:0002883) | 3.50769535 |
| 19 | Ulnar claw (HP:0001178) | 3.39073457 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.25322521 |
| 21 | Broad-based gait (HP:0002136) | 3.24275981 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.21658817 |
| 23 | Dysmetria (HP:0001310) | 3.16637601 |
| 24 | Dysmetric saccades (HP:0000641) | 3.10747594 |
| 25 | Impaired smooth pursuit (HP:0007772) | 3.07136120 |
| 26 | Dysdiadochokinesis (HP:0002075) | 3.04499685 |
| 27 | Pheochromocytoma (HP:0002666) | 2.96327405 |
| 28 | Protruding tongue (HP:0010808) | 2.84655910 |
| 29 | Depression (HP:0000716) | 2.83857958 |
| 30 | Amblyopia (HP:0000646) | 2.82956719 |
| 31 | Insidious onset (HP:0003587) | 2.82647480 |
| 32 | Termporal pattern (HP:0011008) | 2.82647480 |
| 33 | Poor eye contact (HP:0000817) | 2.79333764 |
| 34 | Urinary urgency (HP:0000012) | 2.77154103 |
| 35 | Abnormal social behavior (HP:0012433) | 2.72291059 |
| 36 | Impaired social interactions (HP:0000735) | 2.72291059 |
| 37 | Hemiplegia (HP:0002301) | 2.68835518 |
| 38 | Anxiety (HP:0000739) | 2.63690961 |
| 39 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.63606807 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.61692835 |
| 41 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.61000238 |
| 42 | Impaired vibratory sensation (HP:0002495) | 2.60348186 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.59809867 |
| 44 | Ankle clonus (HP:0011448) | 2.56204736 |
| 45 | Status epilepticus (HP:0002133) | 2.54628424 |
| 46 | Abnormal eating behavior (HP:0100738) | 2.54483204 |
| 47 | Agitation (HP:0000713) | 2.53942454 |
| 48 | Specific learning disability (HP:0001328) | 2.48397170 |
| 49 | Spastic gait (HP:0002064) | 2.48023829 |
| 50 | Absent speech (HP:0001344) | 2.46276310 |
| 51 | Postural instability (HP:0002172) | 2.45821239 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.45525633 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.43301812 |
| 54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.41482387 |
| 55 | Excessive salivation (HP:0003781) | 2.40718879 |
| 56 | Drooling (HP:0002307) | 2.40718879 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.35693781 |
| 58 | Limb dystonia (HP:0002451) | 2.34703790 |
| 59 | Megalencephaly (HP:0001355) | 2.31535100 |
| 60 | Hemiparesis (HP:0001269) | 2.28318539 |
| 61 | Inability to walk (HP:0002540) | 2.26625179 |
| 62 | Increased circulating renin level (HP:0000848) | 2.22164733 |
| 63 | Stereotypic behavior (HP:0000733) | 2.20821099 |
| 64 | Neurofibrillary tangles (HP:0002185) | 2.20790820 |
| 65 | Hammertoe (HP:0001765) | 2.15661282 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.14047779 |
| 67 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.13125028 |
| 68 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.13125028 |
| 69 | Torticollis (HP:0000473) | 2.13042622 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.10427967 |
| 71 | Gait imbalance (HP:0002141) | 2.09947699 |
| 72 | Abnormal ciliary motility (HP:0012262) | 2.09919943 |
| 73 | Incomplete penetrance (HP:0003829) | 2.09244697 |
| 74 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.08526837 |
| 75 | Bradykinesia (HP:0002067) | 2.06965519 |
| 76 | Focal dystonia (HP:0004373) | 2.05865952 |
| 77 | Spastic tetraplegia (HP:0002510) | 2.04596522 |
| 78 | Sleep apnea (HP:0010535) | 2.04592426 |
| 79 | Exotropia (HP:0000577) | 1.99097040 |
| 80 | Hepatoblastoma (HP:0002884) | 1.98590130 |
| 81 | Abnormality of saccadic eye movements (HP:0000570) | 1.96295526 |
| 82 | Gait ataxia (HP:0002066) | 1.95522898 |
| 83 | Progressive inability to walk (HP:0002505) | 1.93983353 |
| 84 | Widely spaced teeth (HP:0000687) | 1.93913431 |
| 85 | Metaphyseal dysplasia (HP:0100255) | 1.92413881 |
| 86 | Thickened helices (HP:0000391) | 1.90533743 |
| 87 | Steppage gait (HP:0003376) | 1.90362797 |
| 88 | Cerebral inclusion bodies (HP:0100314) | 1.89724922 |
| 89 | Congenital primary aphakia (HP:0007707) | 1.89543263 |
| 90 | Abnormal hair whorl (HP:0010721) | 1.89028140 |
| 91 | Peripheral hypomyelination (HP:0007182) | 1.88858656 |
| 92 | Mutism (HP:0002300) | 1.88585355 |
| 93 | Prolonged QT interval (HP:0001657) | 1.88269059 |
| 94 | Blue irides (HP:0000635) | 1.87648807 |
| 95 | Lower limb muscle weakness (HP:0007340) | 1.87573458 |
| 96 | Abnormality of the labia minora (HP:0012880) | 1.86942038 |
| 97 | Alacrima (HP:0000522) | 1.86521284 |
| 98 | Agnosia (HP:0010524) | 1.86215057 |
| 99 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.85611202 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.85351771 |
| 101 | Bradycardia (HP:0001662) | 1.84957156 |
| 102 | Fetal akinesia sequence (HP:0001989) | 1.84474443 |
| 103 | Decreased motor nerve conduction velocity (HP:0003431) | 1.83985381 |
| 104 | Abnormal EKG (HP:0003115) | 1.83604282 |
| 105 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.83452915 |
| 106 | Papillary thyroid carcinoma (HP:0002895) | 1.82634868 |
| 107 | Medial flaring of the eyebrow (HP:0010747) | 1.81886215 |
| 108 | Abnormality of salivation (HP:0100755) | 1.81146220 |
| 109 | Inappropriate behavior (HP:0000719) | 1.80977803 |
| 110 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.80627322 |
| 111 | Absent/shortened dynein arms (HP:0200106) | 1.80627322 |
| 112 | Aqueductal stenosis (HP:0002410) | 1.80561179 |
| 113 | Papilledema (HP:0001085) | 1.80244118 |
| 114 | Intention tremor (HP:0002080) | 1.79195992 |
| 115 | Syncope (HP:0001279) | 1.78519879 |
| 116 | Diplopia (HP:0000651) | 1.77815662 |
| 117 | Abnormality of binocular vision (HP:0011514) | 1.77815662 |
| 118 | Craniofacial dystonia (HP:0012179) | 1.76631194 |
| 119 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.76624740 |
| 120 | Aplasia of the phalanges of the hand (HP:0009802) | 1.76624740 |
| 121 | Aplasia involving bones of the extremities (HP:0009825) | 1.76624740 |
| 122 | Polyphagia (HP:0002591) | 1.76118425 |
| 123 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75895726 |
| 124 | Generalized hypopigmentation of hair (HP:0011358) | 1.74014441 |
| 125 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.70360690 |
| 126 | Astrocytoma (HP:0009592) | 1.69411896 |
| 127 | Abnormality of the astrocytes (HP:0100707) | 1.69411896 |
| 128 | Gastroesophageal reflux (HP:0002020) | 1.69392142 |
| 129 | Clumsiness (HP:0002312) | 1.68817751 |
| 130 | Decreased lacrimation (HP:0000633) | 1.67278131 |
| 131 | Bronchomalacia (HP:0002780) | 1.66739253 |
| 132 | Overgrowth (HP:0001548) | 1.65878021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.19758214 |
| 2 | MAP3K9 | 3.76496694 |
| 3 | MAP3K4 | 3.48204358 |
| 4 | MINK1 | 3.14994399 |
| 5 | MAP2K7 | 2.94848106 |
| 6 | EPHA4 | 2.84811216 |
| 7 | CASK | 2.55228157 |
| 8 | MAP3K12 | 2.52599192 |
| 9 | TNIK | 2.33509037 |
| 10 | MAP2K4 | 2.29418057 |
| 11 | PAK6 | 2.20541893 |
| 12 | CAMKK2 | 2.14632814 |
| 13 | CDK19 | 2.01242375 |
| 14 | LMTK2 | 1.88818437 |
| 15 | MARK1 | 1.87945786 |
| 16 | NTRK2 | 1.71574801 |
| 17 | CAMKK1 | 1.69609819 |
| 18 | SIK3 | 1.69068446 |
| 19 | DAPK1 | 1.69024917 |
| 20 | MAPK13 | 1.68388266 |
| 21 | DAPK2 | 1.60568702 |
| 22 | KSR2 | 1.58851577 |
| 23 | PNCK | 1.51981598 |
| 24 | LATS2 | 1.50551901 |
| 25 | RIPK4 | 1.49042928 |
| 26 | KSR1 | 1.44365343 |
| 27 | PRKCG | 1.39898986 |
| 28 | NTRK1 | 1.35279312 |
| 29 | CDK5 | 1.34993284 |
| 30 | STK38 | 1.31254614 |
| 31 | SGK2 | 1.29836775 |
| 32 | SGK223 | 1.19381276 |
| 33 | SGK494 | 1.19381276 |
| 34 | CAMK2A | 1.15737080 |
| 35 | PHKG1 | 1.15390818 |
| 36 | PHKG2 | 1.15390818 |
| 37 | FRK | 1.15236574 |
| 38 | PRPF4B | 1.14375514 |
| 39 | PIK3CA | 1.12427199 |
| 40 | AKT3 | 1.09680950 |
| 41 | CSNK1A1L | 1.05969005 |
| 42 | PLK2 | 1.04411571 |
| 43 | OXSR1 | 1.01452950 |
| 44 | MAPKAPK3 | 1.00519821 |
| 45 | ARAF | 0.99009590 |
| 46 | CAMK1D | 0.98951418 |
| 47 | FES | 0.95443761 |
| 48 | CDK3 | 0.95124312 |
| 49 | SGK3 | 0.94693020 |
| 50 | CAMK1 | 0.92936139 |
| 51 | WNK1 | 0.90021688 |
| 52 | UHMK1 | 0.89713815 |
| 53 | TAOK1 | 0.89127700 |
| 54 | MAP3K2 | 0.88602364 |
| 55 | CDK18 | 0.86989383 |
| 56 | GRK5 | 0.86227605 |
| 57 | FGFR2 | 0.83079845 |
| 58 | CDK14 | 0.80701685 |
| 59 | BCR | 0.79705003 |
| 60 | PKN1 | 0.79319115 |
| 61 | CAMK2B | 0.78695256 |
| 62 | CDK15 | 0.78290301 |
| 63 | RET | 0.77234574 |
| 64 | PDGFRB | 0.75616435 |
| 65 | CAMK1G | 0.74575731 |
| 66 | BMPR2 | 0.74458569 |
| 67 | WNK3 | 0.73454458 |
| 68 | NEK1 | 0.73220625 |
| 69 | PTK2B | 0.73171734 |
| 70 | FER | 0.72288592 |
| 71 | PAK3 | 0.72140676 |
| 72 | MET | 0.69479564 |
| 73 | SIK2 | 0.69121742 |
| 74 | SGK1 | 0.68060116 |
| 75 | CDC42BPA | 0.67546812 |
| 76 | PDK1 | 0.66835630 |
| 77 | CDK11A | 0.66806823 |
| 78 | STK11 | 0.64848599 |
| 79 | MAP3K13 | 0.64842292 |
| 80 | BRAF | 0.63647643 |
| 81 | MAPK12 | 0.63409953 |
| 82 | CAMK2D | 0.62787263 |
| 83 | STK39 | 0.61040045 |
| 84 | PDPK1 | 0.60802244 |
| 85 | CSNK1D | 0.60710697 |
| 86 | CSNK1G1 | 0.60591230 |
| 87 | DYRK1A | 0.59970320 |
| 88 | TYRO3 | 0.56689732 |
| 89 | DMPK | 0.56305361 |
| 90 | TNK2 | 0.55372984 |
| 91 | RAF1 | 0.54265636 |
| 92 | CSNK1G3 | 0.54038734 |
| 93 | RPS6KA3 | 0.53921402 |
| 94 | PRKCH | 0.53615178 |
| 95 | CAMK4 | 0.53345203 |
| 96 | WNK4 | 0.52576046 |
| 97 | LATS1 | 0.52420271 |
| 98 | CAMK2G | 0.51639571 |
| 99 | PRKCE | 0.50947600 |
| 100 | MAP2K1 | 0.49138467 |
| 101 | PRKD3 | 0.48930255 |
| 102 | CSNK1G2 | 0.48749452 |
| 103 | MAP3K1 | 0.47511715 |
| 104 | SCYL2 | 0.47499908 |
| 105 | PINK1 | 0.44905759 |
| 106 | CSNK1E | 0.43558988 |
| 107 | NEK6 | 0.43258535 |
| 108 | CCNB1 | 0.42263003 |
| 109 | LIMK1 | 0.41023135 |
| 110 | GSK3B | 0.40499765 |
| 111 | RPS6KB1 | 0.40352361 |
| 112 | MAPK10 | 0.40080100 |
| 113 | PRKG1 | 0.39776407 |
| 114 | MARK2 | 0.39510257 |
| 115 | NME1 | 0.39351144 |
| 116 | PRKCB | 0.39266178 |
| 117 | STK38L | 0.36795360 |
| 118 | MAP3K7 | 0.36692435 |
| 119 | PRKACB | 0.36071741 |
| 120 | ADRBK1 | 0.35129717 |
| 121 | CSNK1A1 | 0.34991856 |
| 122 | PRKCZ | 0.34428498 |
| 123 | FYN | 0.33854493 |
| 124 | PRKACA | 0.33794745 |
| 125 | BRD4 | 0.31808446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.96588003 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.62822994 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.83648125 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.70370163 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.68160434 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.56558879 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54823851 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.53158720 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43071363 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.36087790 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.34569198 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.23181172 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.18542687 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.12961102 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.98476712 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.88682127 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.80346309 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74583528 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.69799672 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69774807 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.69363407 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66866799 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63982259 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63877354 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.63034966 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.58988186 |
| 27 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.45121909 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43138306 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.42316416 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41029401 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.29618499 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28090104 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.26799338 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25253046 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22973313 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21616197 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.18355050 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17634389 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11912065 |
| 40 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09187551 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02846686 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99559909 |
| 43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99324177 |
| 44 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97845274 |
| 45 | Axon guidance_Homo sapiens_hsa04360 | 0.96609166 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94954642 |
| 47 | Glioma_Homo sapiens_hsa05214 | 0.94725898 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87633951 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87572010 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87476867 |
| 51 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86123301 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84337775 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 0.82855508 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75758124 |
| 55 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74977137 |
| 56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72647655 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71790786 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65622448 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65337841 |
| 60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65179514 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65111498 |
| 62 | Phototransduction_Homo sapiens_hsa04744 | 0.63946105 |
| 63 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61006421 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59923713 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59060875 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56393711 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.56161181 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.54753366 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53915612 |
| 70 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.52371131 |
| 71 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52289248 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51531183 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50734741 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50463049 |
| 75 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.49394018 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49235485 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48922421 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48846736 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47605420 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46815815 |
| 81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45916589 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45001911 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44813882 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44523175 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.42142926 |
| 86 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.41821265 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.41091999 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40825171 |
| 89 | Bile secretion_Homo sapiens_hsa04976 | 0.40446505 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.40207136 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40169536 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.38876051 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37487343 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36063927 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33516487 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33454618 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.33172384 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32344466 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.29795341 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.29491121 |
| 101 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29360908 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29018730 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28567069 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27335044 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.26816889 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.26323766 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26299872 |
| 108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26181073 |
| 109 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.25275310 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.24126927 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24105738 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23985576 |
| 113 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.23873763 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.23052772 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.22751391 |
| 116 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22431240 |

